The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort study

被引：3
|
作者：
Truyens, M. [1 ,2 ,3 ,4 ]
De Galan, C. [1 ,3 ,4 ]
Peeters, H. [5 ]
Mesonero Gismero, F. [6 ]
Elorza, A. [7 ]
Torres, P. [8 ]
Vandermeulen, L. [9 ]
Amezaga, A. Jauregui [10 ]
Ferreiro-Iglesias, R. [11 ]
Holvoet, T. [12 ]
Zabana, Y. [13 ,14 ]
Reverter, L. Peries [15 ]
Geldof, J. [2 ]
Varkas, G. [4 ,16 ]
De Vos, M. [1 ,2 ,3 ]
Lobaton, T. [1 ,2 ]
机构：
[1] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium
[2] Univ Hosp Ghent, Dept Gastroenterol, Ghent, Belgium
[3] Univ Ghent, Ghent Gut Inflammat Grp GGIG, Ghent, Belgium
[4] Univ Ghent, VIB Ctr Inflammat Res IRC, Ghent, Belgium
[5] AZ Sint Lucas, Dept Gastroenterol, Ghent, Belgium
[6] Hosp Ramon & Cajal, Dept Gastroenterol, Madrid, Spain
[7] Hosp Galdakao, Dept Gastroenterol, Bilbao, Spain
[8] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Barcelona, Spain
[9] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel, Dept Gastroenterol, Brussels, Belgium
[10] Univ Hosp Antwerp, Dept Gastroenterol, Antwerp, Belgium
[11] Hosp Clin Univ Santiago, Dept Gastroenterol, Santiago De Compostela, Spain
[12] AZ Nikolaas, Dept Gastroenterol, St Niklaas, Belgium
[13] Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain
[14] Hosp Univ Mutua Terrassa, CIBERehd, Barcelona, Spain
[15] Hosp Univ Girona, Dept Gastroenterol, Girona, Spain
[16] Univ Hosp Ghent, Dept Rheumatol, Ghent, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.391
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P266
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [21] Impact of Mogamulizumab in Real-Life Advanced Cutaneous T-Cell Lymphomas: A Multicentric Retrospective Cohort Study
    Jouandet, Marie
    Nakouri, Ines
    Nadin, Lawrence
    Kieny, Alice
    Samimi, Mahtab
    Adamski, Henri
    Quereux, Gaelle
    Chaby, Guillaume
    Dompmartin, Anne
    L'orphelin, Jean-Matthieu
    CANCERS, 2022, 14 (07)
  • [22] Vedolizumab Dose Escalation in a Real-World Cohort of IBD Patients
    Zelinkova, Z.
    Kadleckova, B.
    Lucenicova, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S454 - S454
  • [23] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Rullan, M.
    Elosua, A.
    Saldana, C.
    Amorena, E.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S453 - S454
  • [24] Ustekinumab induction effectiveness in Crohn's disease in a real-life cohort
    Sanchez Rodriguez, E.
    Mesonero Gismero, F.
    Lopez Sanroman, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S590 - S591
  • [25] EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE
    Ylisaukko-Oja, T.
    Torvinen, S.
    Aaltonen, J.
    Vihervaara, V.
    Eberl, A.
    Nuutinen, H.
    Blomster, T.
    Jussila, A.
    Pajala, M.
    Jokelainen, J.
    Herrala, S.
    Tamminen, K.
    Sipponen, T.
    VALUE IN HEALTH, 2017, 20 (05) : A180 - A180
  • [26] Role of integrin expression in the prediction of response to vedolizumab: A prospective real-life multicentre cohort study
    De Galan, Cara
    Gonzales, Gerard Bryan
    Van Welden, Sophie
    Tavernier, Simon Jan
    Lobaton, Triana
    Van Moerkercke, Wouter
    Strubbe, Beatrijs
    Peeters, Harald
    Macken, Elisabeth
    De Vos, Martine
    Laukens, Debby
    Hindryckx, Pieter
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (04):
  • [27] Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland
    Eberl, A.
    Hallinen, T.
    af Bjorkesten, C. -G.
    Heikkinen, M.
    Hirsi, E.
    Kellokumpu, M.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nuutinen, H.
    Suhonen, U. -M.
    Utriainen, K.
    Vihriala, I.
    Soini, E.
    Wennerstrom, C.
    Nissinen, R.
    Borsi, A.
    Koivunen, M.
    Tillonen, J.
    Sipponen, T.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S415 - S416
  • [28] Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
    Eberl, Anja
    Hallinen, Taru
    af Bjorkesten, Clas-Goran
    Heikkinen, Markku
    Hirsi, Eija
    Kellokumpu, Mikko
    Koskinen, Inka
    Moilanen, Veikko
    Nielsen, Christian
    Nuutinen, Heikki
    Suhonen, Ulla-Maija
    Utriainen, Karri
    Vihriala, Ilkka
    Soini, Erkki
    Wennerstrom, Christina
    Nissinen, Riikka
    Borsi, Andras
    Koivunen, Minni
    Tillonen, Jyrki
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 718 - 725
  • [29] Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort
    Verstockt, B.
    Vieujean, S.
    Truyens, M.
    Julsgaard, M.
    Pugliese, D.
    Aslan, D.
    Prokopic, M.
    Lim, S.
    Vigano, C.
    Festa, S.
    Ramos, L.
    Garcia, M. J.
    Plaza, R.
    Noviello, D.
    Savarino, E.
    Drobne, D.
    Imperatore, N.
    Ribaldone, D. G.
    Van Dongen, J.
    Teich, N.
    Wahed, M.
    Barberio, B.
    Goren, I.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 805 - 805
  • [30] LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN IBD PATIENTS: A REAL-LIFE EXPERIENCE FROM A TERTIARY REFERRAL CENTER
    Dragoni, G.
    Zu Schwabedissen, A. Meyer
    Manetti, N.
    Le Grazie, M.
    Campani, C.
    Bensi, C.
    Galli, A.
    Bagnoli, S.
    Milla, M.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E240 - E241
12345